U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07297940) titled 'Phamacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State' on Dec. 09.
Brief Summary: This clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01 at fasting state.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: DA-1229_01
single dose administration (DA-1229 one tablet once a day)
DRUG: DA-1229_01-R
single dose administration (DA-1229\_01-R one tablet once d day)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Dong-A ST Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....